Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort

Cross sectional studies of patients at risk of developing Alzheimer disease (AD) have identified several brain regions known to be prone to degeneration suitable as biomarkers, including hippocampal, ventricular, and whole brain volume. The aim of this study was to longitudinally evaluate an index based on morphometric measures derived from MRI data that could be used for classification of AD and healthy control subjects, as well as prediction of conversion from mild cognitive impairment (MCI) to AD. Patients originated from the AddNeuroMed project at baseline (119 AD, 119 MCI, 110 controls (CTL)) and 1-year follow-up (62 AD, 73 MCI, 79 CTL). Data consisted of 3D T1-weighted MR images, demographics, MMSE, ADAS-Cog, CERAD and CDR scores, and APOE e4 status. We computed an index using a multivariate classification model (AD vs. CTL), using orthogonal partial least squares to latent structures (OPLS). Sensitivity, specificity and AUC were determined. Performance of the classifier (AD vs. CTL) was high at baseline (10-fold cross-validation, 84% sensitivity, 91% specificity, 0.93 AUC) and at 1-year follow-up (92% sensitivity, 74% specificity, 0.93 AUC). Predictions of conversion from MCI to AD were good at baseline (77% of MCI converters) and at follow-up (91% of MCI converters). MCI carriers of the APOE e4 allele manifested more atrophy and presented a faster cognitive decline when compared to non-carriers. The derived index demonstrated a steady increase in atrophy over time, yielding higher accuracy in prediction at the time of clinical conversion. Neuropsychological tests appeared less sensitive to changes over time. However, taking the average of the two time points yielded better correlation between the index and cognitive scores as opposed to using cross-sectional data only. Thus, multivariate classification seemed to detect patterns of AD changes before conversion from MCI to AD and including longitudinal information is of great importance.

[1]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[2]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[3]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[4]  H. Benali,et al.  Support vector machine-based classification of Alzheimer’s disease from whole-brain anatomical MRI , 2009, Neuroradiology.

[5]  U. Edlund,et al.  Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. , 2008, Analytical chemistry.

[6]  Lars Bäckman,et al.  Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.

[7]  S. Wold,et al.  Orthogonal projections to latent structures (O‐PLS) , 2002 .

[8]  J. Lambert,et al.  Genetics of Alzheimer's disease: new evidences for an old hypothesis? , 2011, Current opinion in genetics & development.

[9]  A. Dale,et al.  Improved Localizadon of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach , 1993, Journal of Cognitive Neuroscience.

[10]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[11]  S Lovestone,et al.  Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α‐/γ‐tocotrienols and γ‐tocopherol , 2013, Journal of internal medicine.

[12]  Magda Tsolaki,et al.  Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. , 2010, Journal of Alzheimer's disease : JAD.

[13]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[14]  A. Dale,et al.  High‐resolution intersubject averaging and a coordinate system for the cortical surface , 1999, Human brain mapping.

[15]  A. Hariri,et al.  A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology , 2013, Molecular Psychiatry.

[16]  S. Resnick,et al.  Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. , 2009, Brain : a journal of neurology.

[17]  K. Hawkins,et al.  The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis , 2011, Neurobiology of Aging.

[18]  Susan M Resnick,et al.  Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. , 2010, Archives of general psychiatry.

[19]  Anders M. Dale,et al.  Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.

[20]  H. Soininen,et al.  A disease state fingerprint for evaluation of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[21]  Cedric E. Ginestet,et al.  No differences in hippocampal volume between carriers and non-carriers of the ApoE ε4 and ε2 alleles in young healthy adolescents. , 2014, Journal of Alzheimer's disease : JAD.

[22]  L. Fratiglioni,et al.  The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age , 2013, Front. Hum. Neurosci..

[23]  Clifford R. Jack,et al.  Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies , 2008, NeuroImage.

[24]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[25]  Christian Böhm,et al.  Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease , 2010, NeuroImage.

[26]  Maximilian Reiser,et al.  Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment , 2007, NeuroImage.

[27]  S. Resnick,et al.  Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging , 2008, Neurobiology of Aging.

[28]  T. Goldberg,et al.  The genetics of episodic memory , 2009, Cognitive neuropsychiatry.

[29]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[30]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[31]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[32]  D. Louis Collins,et al.  Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls , 2011, NeuroImage.

[33]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[34]  P. Mecocci,et al.  An MRI‐based index to measure the severity of Alzheimer's disease‐like structural pattern in subjects with mild cognitive impairment , 2013, Journal of internal medicine.

[35]  A. Simmons,et al.  Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[36]  Nouna Kettaneh-Wold,et al.  Analysis of mixture data with partial least squares , 1992 .

[37]  A. Simmons,et al.  Regional Magnetic Resonance Imaging Measures for Multivariate Analysis in Alzheimer’s Disease and Mild Cognitive Impairment , 2012, Brain Topography.

[38]  M. Rantalainen,et al.  OPLS discriminant analysis: combining the strengths of PLS‐DA and SIMCA classification , 2006 .

[39]  Eric Westman,et al.  Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion , 2012, NeuroImage.

[40]  C. Jack,et al.  Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.

[41]  C. Jack,et al.  MRI and CSF biomarkers in normal, MCI, and AD subjects , 2009, Neurology.

[42]  Anders M. Dale,et al.  Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex , 2001, IEEE Transactions on Medical Imaging.

[43]  M. Sano,et al.  An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease , 1997, Alzheimer disease and associated disorders.

[44]  A. Simmons,et al.  Different multivariate techniques for automated classification of MRI data in Alzheimer’s disease and mild cognitive impairment , 2013, Psychiatry Research: Neuroimaging.

[45]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[46]  J. Haines,et al.  Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease , 1995, Neurology.

[47]  Nick C Fox,et al.  Automatic classification of MR scans in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[48]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[49]  Christos Davatzikos,et al.  Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI , 2009, NeuroImage.

[50]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[51]  et al.,et al.  Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline , 2008, NeuroImage.

[52]  Wendy R. Sanhai,et al.  Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives , 2010, Nature Reviews Drug Discovery.

[53]  Keith A. Johnson,et al.  Preclinical Alzheimer disease—the challenges ahead , 2013, Nature Reviews Neurology.

[54]  Anders M. Dale,et al.  A hybrid approach to the Skull Stripping problem in MRI , 2001, NeuroImage.

[55]  E. Westman,et al.  Cognitive decline is mediated by gray matter changes during middle age , 2014, Neurobiology of Aging.

[56]  Charles D. Smith Structural imaging in early pre-states of dementia. , 2012, Biochimica et biophysica acta.

[57]  A. Simmons,et al.  MRI Measures of Alzheimer's Disease and the AddNeuroMed Study , 2009, Annals of the New York Academy of Sciences.

[58]  Bruce Fischl,et al.  Geometrically Accurate Topology-Correction of Cortical Surfaces Using Nonseparating Loops , 2007, IEEE Transactions on Medical Imaging.

[59]  Mark Jenkinson,et al.  Structural MRI changes detectable up to ten years before clinical Alzheimer's disease , 2012, Neurobiology of Aging.

[60]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[61]  M. D. O'Brien,et al.  Cerebral blood flow in dementia , 1986, Neurology.

[62]  Robert Fox,et al.  New rating scale , 1993 .

[63]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J T O'Brien,et al.  Role of imaging techniques in the diagnosis of dementia. , 2007, The British journal of radiology.

[65]  L. Ferrucci,et al.  Longitudinal imaging pattern analysis (SPARE-CD index) detects early structural and functional changes before cognitive decline in healthy older adults , 2012, Neurobiology of Aging.

[66]  J. Dukart,et al.  Age Correction in Dementia – Matching to a Healthy Brain , 2011, PloS one.

[67]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[68]  A. Simmons,et al.  Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups—The AddNeuroMed study , 2011, Neurobiology of Aging.

[69]  Andrew Simmons,et al.  Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls. , 2010, Journal of Alzheimer's disease : JAD.

[70]  Kiralee M. Hayashi,et al.  Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. , 2006, Archives of neurology.

[71]  Viswanath Devanarayan,et al.  Derivation of a New ADAS-cog Composite Using Tree-based Multivariate Analysis: Prediction of Conversion From Mild Cognitive Impairment to Alzheimer Disease , 2011, Alzheimer disease and associated disorders.

[72]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[73]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[74]  Alan C. Evans,et al.  APOE ε2 Allele Is Associated with Larger Regional Cortical Thicknesses and Volumes , 2010, Dementia and Geriatric Cognitive Disorders.

[75]  Magda Tsolaki,et al.  The AddNeuroMed framework for multi‐centre MRI assessment of Alzheimer's disease : experience from the first 24 months , 2011, International journal of geriatric psychiatry.

[76]  N. Butters,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.

[77]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[78]  Marie Chupin,et al.  Automatic classi fi cation of patients with Alzheimer ' s disease from structural MRI : A comparison of ten methods using the ADNI database , 2010 .

[79]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[80]  J. Nicholas,et al.  APOE Genotype in the Diagnosis of Alzheimer’s Disease in Patients With Cognitive Impairment , 2012, American journal of Alzheimer's disease and other dementias.

[81]  Sterling C. Johnson,et al.  Magnetic Resonance Imaging Characterization of Brain Structure and Function in Mild Cognitive Impairment: A Review , 2008, Journal of the American Geriatrics Society.

[82]  R. Rimondini,et al.  Combination of apolipoprotein E4 and high carbohydrate diet reduces hippocampal BDNF and arc levels and impairs memory in young mice. , 2012, Journal of Alzheimer's disease : JAD.

[83]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[84]  Eileen Daly,et al.  Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer’s disease , 2008, Journal of Neurology.